221 related articles for article (PubMed ID: 8205528)
21. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
[TBL] [Abstract][Full Text] [Related]
23. Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage.
Maeurer MJ; Hurd S; Martin DM; Storkus WJ; Lotze MT
Cancer J Sci Am; 1995; 1(2):162-70. PubMed ID: 9166469
[TBL] [Abstract][Full Text] [Related]
24. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
25. HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer.
Peoples GE; Goedegebuure PS; Andrews JV; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5481-91. PubMed ID: 8228240
[TBL] [Abstract][Full Text] [Related]
26. Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma.
Aarntzen EH; Bol K; Schreibelt G; Jacobs JF; Lesterhuis WJ; Van Rossum MM; Adema GJ; Figdor CG; Punt CJ; De Vries IJ
Cancer Res; 2012 Dec; 72(23):6102-10. PubMed ID: 23010076
[TBL] [Abstract][Full Text] [Related]
27. Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma.
Ksander BR; Rubsamen PE; Olsen KR; Cousins SW; Streilein JW
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3198-208. PubMed ID: 1748551
[TBL] [Abstract][Full Text] [Related]
28. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
Brichard V; Van Pel A; Wölfel T; Wölfel C; De Plaen E; Lethé B; Coulie P; Boon T
J Exp Med; 1993 Aug; 178(2):489-95. PubMed ID: 8340755
[TBL] [Abstract][Full Text] [Related]
29. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
Topalian SL; Rivoltini L; Mancini M; Markus NR; Robbins PF; Kawakami Y; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9461-5. PubMed ID: 7937789
[TBL] [Abstract][Full Text] [Related]
30. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
Kawakami Y; Eliyahu S; Delgado CH; Robbins PF; Sakaguchi K; Appella E; Yannelli JR; Adema GJ; Miki T; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6458-62. PubMed ID: 8022805
[TBL] [Abstract][Full Text] [Related]
31. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope.
Wolchok JD; Chapman PB
J Clin Oncol; 2002 Jul; 20(14):3176; author reply 3176-7. PubMed ID: 12118032
[No Abstract] [Full Text] [Related]
32. Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma.
Schmittel A; Keilholz U; Max R; Thiel E; Scheibenbogen C
Int J Cancer; 1999 Jan; 80(1):39-43. PubMed ID: 9935227
[TBL] [Abstract][Full Text] [Related]
33. Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression.
Khong HT; Wang QJ; Rosenberg SA
J Immunother; 2004; 27(3):184-90. PubMed ID: 15076135
[TBL] [Abstract][Full Text] [Related]
34. N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4(+) T cells.
Housseau F; Moorthy A; Langer DA; Robbins PF; Gonzales MI; Topalian SL
Eur J Immunol; 2001 Sep; 31(9):2690-701. PubMed ID: 11536167
[TBL] [Abstract][Full Text] [Related]
35. Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.
Coulie PG; Weynants P; Lehmann F; Herman J; Brichard V; Wölfel T; Van Pel A; De Plaen E; Brasseur F; Boon T
J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):104-9. PubMed ID: 8280701
[TBL] [Abstract][Full Text] [Related]
36. Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy.
Zhou J; Dudley ME; Rosenberg SA; Robbins PF
J Immunother; 2005; 28(1):53-62. PubMed ID: 15614045
[TBL] [Abstract][Full Text] [Related]
37. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes.
Wang RF; Robbins PF; Kawakami Y; Kang XQ; Rosenberg SA
J Exp Med; 1995 Feb; 181(2):799-804. PubMed ID: 7836932
[TBL] [Abstract][Full Text] [Related]
38. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
Topalian SL; Gonzales MI; Parkhurst M; Li YF; Southwood S; Sette A; Rosenberg SA; Robbins PF
J Exp Med; 1996 May; 183(5):1965-71. PubMed ID: 8642306
[TBL] [Abstract][Full Text] [Related]
39. T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.
Huang J; El-Gamil M; Dudley ME; Li YF; Rosenberg SA; Robbins PF
J Immunol; 2004 May; 172(10):6057-64. PubMed ID: 15128789
[TBL] [Abstract][Full Text] [Related]
40. Frequency of human leukocyte antigen-A 24 alleles in patients with melanoma determined by human leukocyte antigen-A sequence-based typing.
Bettinotti MP; Norris RD; Hackett JA; Thompson CO; Simonis TB; Stroncek D; Marincola FM
J Immunother; 2000; 23(2):282-7. PubMed ID: 10746555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
